Study of the "in vitro" and "in vivo" effects of antibiotics on Klebsiella rhinoscleromatis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D002751:Chlortetracycline / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007709:Klebsiella / Q000187:drug effects* / Q000302:isolation & purification; D008709:Methenamine / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D009827:Oleandomycin / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D012226:Rhinoscleroma / Q000188:drug therapy*; D012382:Rolitetracycline / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D013424:Sulfanilamides; D013449:Sulfonamides; D007612:Kanamycin; D002701:Chloramphenicol; D009582:Nitrofurantoin; D013752:Tetracycline; D012382:Rolitetracycline; D008709:Methenamine; D009827:Oleandomycin; D002751:Chlortetracycline; D010118:Oxytetracycline; D013307:Streptomycin; D003091:Colistin